Product Information
CROMOLYN 20 MG/2 ML NEB SOLN is a generic product labeled by Ritedose Pharmaceuticals, LLC, priced at $0.9626 per ML under NDC 76204002860. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Oct 16, 2017. Its Orange Book therapeutic-equivalence code is AN.
Strength
20 mg/2mL
Manufacturer
Ritedose Pharmaceuticals, LLCNDC
76204002860
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
CROMOLYN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA209453FDA Approved
10/16/2017
TE Code
AN
On Market Since
12/1/2021
Pharmacological Classes
Price Statistics
The NADAC for CROMOLYN 20 MG/2 ML NEB SOLN has been published 117 times since Jul 10, 2024, and over the history we have for it it has declined 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9626 per ML |
|---|---|
| All-time high | $2.0247 (Aug 14, 2024) |
| All-time low | $0.5505 (Jun 18, 2025) |
| 52-week high | $1.0554 |
| 52-week low | $0.5662 |
| Median price | $0.9626 |
| Average price | $0.9410 |
| Largest weekly change | -48.1% (Sep 18, 2024) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cromolyn Sodium Inhalation Solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ritedose Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cromolyn Sodium Inhalation Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CROMOLYN 20 MG/2 ML NEB SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 20 MG/2 ML NEB SOLN, manufactured by Ritedose Pharmaceuticals, LLC, is $0.9626 per ML (NDC 76204002860), effective Sep 30, 2026.
How has the price of CROMOLYN 20 MG/2 ML NEB SOLN changed over time?
Over the history we have for it, the NADAC for CROMOLYN 20 MG/2 ML NEB SOLN has declined 38.5%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for CROMOLYN 20 MG/2 ML NEB SOLN?
Since Jul 10, 2024, the NADAC for CROMOLYN 20 MG/2 ML NEB SOLN has ranged from a low of $0.5505 (Jun 18, 2025) to a high of $2.0247 (Aug 14, 2024), with a median of $0.9626 per ML.
Are there cheaper alternatives to CROMOLYN 20 MG/2 ML NEB SOLN?
No other NADAC-published product currently shares the active ingredient and strength of CROMOLYN 20 MG/2 ML NEB SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CROMOLYN 20 MG/2 ML NEB SOLN?
CROMOLYN 20 MG/2 ML NEB SOLN (NDC 76204002860) is labeled by Ritedose Pharmaceuticals, LLC, and CMS classifies it as a generic product.